About
Basic Data Updated:
2 months agoThe Corporate was formerly known as Apex Drugs And Intermediates Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 25.00 cr and a paid-up capital of Rs 2.00 cr.
The Corporate has already closed loans amounting to ₹135.21 cr, and has no open charges as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Apex Drugs Limited India is Shankar Dige as Cfo. Shankar Dige, Gajanana Kudva, and Kajal Damania serve as directors at the Company.
Industry
Company Details
- Location
Jinnaram, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24230TG1989PLC010737 |
| Company No. | 010737 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 05 Dec 1989 |
| Date of AGM | 30 Sep 2022 |
| Date of Balance Sheet | 31 Mar 2022 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Apex Drugs Limited
Apex Drugs Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 101.5%.
Corporate Structure
Unlock access to Apex Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Apex Drugs Limited
Unlock and access historical data on people associated with Apex Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
SD
Shankar Dige CFOAppointment Date: 15-Sep-2021
Status: Current
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 01 Dec 2010 | ₹16.00 Cr | Satisfied |
Bank Of India Creation Date: 12 Sep 2008 | ₹23.85 Cr | Satisfied |
Icici Bank Limited Creation Date: 23 Apr 2007 | ₹22.20 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Mvk Lifesciences Private Limited
Active
2 years 11 months Gajanana Kudva and Kajal Damania are mutual person
Recent activity within the organization
Annual General Meeting
Apex Drugs Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
30 Sep 2022Balance Sheet
Apex Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
31 Mar 2022Charges
A charge registered on 01 Dec 2010 via Charge ID 10254676 with Allahabad Bank was fully satisfied on 15 Sep 2021.
15 Sep 2021Charges
A charge registered on 12 Sep 2008 via Charge ID 10124609 with Bank Of India was fully satisfied on 15 Sep 2021.
15 Sep 2021Director Appointment
Shankar Sitaram Dige was appointed as a Cfo was appointed as a Cfo on 15 Sep 2021 & has been associated with this company since 3 years 6 days .
15 Sep 2021
Frequently asked questions
What is the Incorporation or founding date of Apex Drugs Limited?
